Identifying prevalence and nature of physical and psychosocial symptoms in breast cancer survivors seen at a tertiary referral breast cancer centre

Breast Cancer Research Centre-WA0 个研究点目标入组 298 人开始时间: 2018年2月14日最近更新: 2022年3月14日

适应症

试验速览

暂无简介。

•1. Provision of written informed consent
•2. At least 18 years of age at the time of consent
•3. Diagnosis of early (non-metastatic) breast cancer. This includes patients diagnosed with DCIS only, provided they have undergone surgery.
•4. Have undergone definitive breast surgery
•5. Have completed recommended chemotherapy with or without trastuzumab treatment and/or targeted radiation therapy as part of their adjuvant treatment (patients who did not complete planned treatment as a consequence of intolerable toxicity and/or at the recommendation of the treating breast specialist remain eligible for inclusion). Patients for whom no chemotherapy was recommended are also eligible.
•6. Patients must have received their surgical, systemic and/or radiation treatment under the care of a doctor at BCRC-WA
•7. Patients who were diagnosed with any psychological disorder prior to or following breast cancer diagnosis are eligible
•8. Clinically assessed as disease-free by the treating clinician at the time of study consent
•9. Commits to completing all questionnaires online within 42 days of consent. This is estimated to take up to 30 minutes, which does not need to be done at one time point.

•1. Patients who do not regard Western Australia as their state of residence.
•2. Patients who work and live outside Western Australia > 6 months of the year.
•3. Patients who are unable to read and understand English
•4. Patients who have declined part or all recommended breast cancer treatment against medical advice.

发起方

Breast Cancer Research Centre-WA